MedPAC Passes Part D Proposals That Could Save $10 Billion

Congress' Medicare advisers unanimously passed a package of Part D recommendations estimated to save $10 billion over five years, including changing cost sharing for Low Income Subsidy beneficiaries and eliminating two protected drug classes, though some commissioners expressed reservations about certain areas. Pharmaceutical Research and Manufacturers of America and Partnership for Part D Access, which includes patient groups and others, quickly came out against the proposals. “PhRMA strongly opposes the sweeping new Medicare Part D recommendations approved by MedPAC earlier...